Investor Presentation J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation
Investor Presentation J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Enclosed please find the presentation the Company proposes to make to investors/analysts on performance of the Company for the quarter ended on December 31, 2022.
Investor Presentation J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Presentation at JP Morgan Healthcare Conference, SFO US
Investor Presentation J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India investors/analysts presentation the Company proposes to on performance of the Company for the quarter ended on September 30, 2022.
Investor Presentation J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation
Investor Presentation J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor presentation on financial results for the quarter and year ended on March 31, 2022.
Investor Presentation J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation
Investor Presentation J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation
Investor Presentation J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation
Investor Presentation J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Company Presentation